Dr. Gerald Batist is Professor of Oncology at McGill University and was University Chair of Oncology for 10 years. He is Deputy Director and leader of the Cancer Axis of the Lady Davis Institute for Medical Research. Dr. Batist led the development of the Segal Cancer Centre, which intimately links research and clinical care and has generated novel treatment models. He co-created the Q-CROC Quebec-wide network and was a co-founder the WIN global consortium for personalized medicine, which is based in Paris.

 Dr. Batist is a medical oncologist and molecular pharmacologist, whose research focuses on novel drug development and therapeutic resistance. He has published over 200 papers and book chapters and shares multiple patents for new chemical entities with novel therapeutic potential. Dr. Batist has achieved significant funding for personalized medicine initiatives, leading large groups in biopsy-driven innovative studies designed to identify molecular signatures of resistance and novel therapeutic targets.

 In 2016, Dr. Batist was appointed Member of the Order of Canada and Knight of the National Order of Quebec. More recently, he was named a Fellow of the Royal Society of Canada (RSC).